Sun Pharma share price ends at ₹1,902.30; slips 0.12% on November 11
Anupama VM
- 0 min read
Last Updated: 11th November 2026 - 05:26 pm
Key Takeaways
Sun Pharma closed almost flat at ₹1,902.30, down 0.12%, despite a ₹49 session range from ₹1,890 to ₹1,939.
The closing price remained above all three tracked moving averages, including the 200-day DMA of ₹1,816.10.
One-year return stood at 12.04%, while the three-month reading was negative at 2.17%.
Sun Pharmaceutical Industries share price finished November 11 at ₹1,902.30, down ₹2.20 or 0.12%. The stock opened at ₹1,939 against a previous close of ₹1,905. Its opening level also matched the session high, while the day's low reached ₹1,890. The resulting ₹49 range was considerably wider than the small final percentage decline. The close was ₹36.70 below the high and ₹12.30 above the low.
Volume reached 2,340,352 shares. Sun Pharma remained above each of the moving averages displayed. The 50-day DMA was ₹1,821, leaving the close ₹81.30 higher. The 100-day DMA stood at ₹1,833.80 and the 200-day DMA at ₹1,816.10. The closing value was ₹86.20 above the 200-day figure.
The stock's 52-week range extended from ₹1,584 to ₹2,047. November 11 ended ₹318.30 above the annual low and ₹144.70 below the high. The annual spread therefore measured ₹463.
Returns were positive across three of the four periods. One-month performance stood at 8.09%, while three-month return was -2.17%. Six-month performance recovered to 2.94%, and the one-year return stood at 12.04%. The gap between three-month and one-year readings was 14.21 percentage points. Sun Pharma's November 11 session therefore featured an almost flat close despite a wider intraday swing, with the final price remaining above all three moving averages.
Frequently Asked Questions
What was the Sun Pharma share price on November 11?
Was Sun Pharma above its 200-day DMA?
What was Sun Pharma's one-year return?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.